Biotech IPO Winter May Last Until 2026 As Headwinds Mount

zerohedge.com/markets/biotech-ipo-winter-may-last-until-2026-headwinds-mount

Biotech IPO Winter May Last Until 2026 As Headwinds Mount

The IPO and secondary equity markets for biotech and biopharma have been in a deep freeze this year, and any thawing isn't expected to materialize until 2026.
Multiple headwinds are weighing on the biotech world, including…

This story appeared on zerohedge.com, 2025-05-29 11:45:00.
The Entire Business World on a Single Page. Free to Use →